Literature DB >> 15184270

No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.

Heather Spencer Feigelson1, Carmen Rodriguez, Eric J Jacobs, W Ryan Diver, Michael J Thun, Eugenia E Calle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15184270

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  9 in total

1.  Unique SNP in CD44 intron 1 and its role in breast cancer development.

Authors:  Juhua Zhou; Prakash S Nagarkatti; Yin Zhong; Kim Creek; Jiajia Zhang; Mitzi Nagarkatti
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

Review 2.  Estrogen and progesterone receptors: from molecular structures to clinical targets.

Authors:  Stephan Ellmann; Heinrich Sticht; Falk Thiel; Matthias W Beckmann; Reiner Strick; Pamela L Strissel
Journal:  Cell Mol Life Sci       Date:  2009-03-31       Impact factor: 9.261

3.  Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.

Authors:  Kerryn W Reding; Christopher I Li; Noel S Weiss; Chu Chen; Christopher S Carlson; David Duggan; Kenneth E Thummel; Janet R Daling; Kathleen E Malone
Journal:  Am J Epidemiol       Date:  2009-10-21       Impact factor: 4.897

4.  Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.

Authors:  Rabeb M Ghali; Maryam A Al-Mutawa; Bashayer H Ebrahim; Hanen H Jrah; Sonia Zaied; Hanen Bhiri; Fahmi Hmila; Touhami Mahjoub; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2018-01-04       Impact factor: 3.201

5.  Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

Authors:  Eunjung Lee; Sue A Ingles; David Van Den Berg; Wei Wang; Chris Lavallee; Mei-Hua Huang; Carolyn J Crandall; Frank Z Stanczyk; Gail A Greendale; Giske Ursin
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

6.  Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.

Authors:  Brenda Diergaarde; John D Potter; Eldon R Jupe; Sharmila Manjeshwar; Craig D Shimasaki; Thomas W Pugh; Daniele C Defreese; Bobby A Gramling; Ilonka Evans; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

7.  +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.

Authors:  Joanne Kotsopoulos; Shelley S Tworoger; Immaculata De Vivo; Immaculata DeVivo; Susan E Hankinson; David J Hunter; Walter C Willett; Wendy Y Chen
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

Review 8.  No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis.

Authors:  Xing-Ling Qi; Jun Yao; Yong Zhang
Journal:  BMC Med Genet       Date:  2017-10-30       Impact factor: 2.103

9.  Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.

Authors:  Sanjib Chaudhary; Aditya K Panda; Dipti Ranjan Mishra; Sandip K Mishra
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.